Seagen (SGEN) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free SGEN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTwo Brothers, a Big Biotech Bet and an $8 Billion Payoutwsj.com - April 13 at 10:00 AMRon Baron Portfolio Magic: Building Your Financial Futuremsn.com - March 20 at 5:13 PMBailouts are back, Fed outlook reassessed, Pfizer M&A - what's moving marketsmsn.com - March 13 at 5:52 PMPfizer shutting down Seagen's $350M construction project in Everettbizjournals.com - March 1 at 9:50 PMNeuralink’s First Brain Implant Patient Can Control Mouse with Thoughts, Musk Saysfinance.yahoo.com - February 24 at 7:17 PMMRNA Feb 2024 64.000 putfinance.yahoo.com - February 23 at 7:52 PMMRNA Feb 2024 77.000 callfinance.yahoo.com - February 23 at 2:51 PMPfizer adds bull at Guggenheim on ex-COVID prospectsmsn.com - February 23 at 9:51 AMMRNA Feb 2024 67.000 putfinance.yahoo.com - February 22 at 7:42 PMPfizer touts cancer efforts in first Super Bowl commercialmsn.com - February 12 at 8:08 AMPRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Movesfinance.yahoo.com - February 10 at 6:20 AMPfizer Q4 results on deck amid gloomy earnings outlookmsn.com - January 29 at 1:59 PMPro Research: Wall Street eyes Seagen's growth trajectoryza.investing.com - January 28 at 1:55 AMAllspring Global Investments Holdings LLC Lowers Stake in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - January 16 at 6:35 AMYelin Lapidot Holdings Management Ltd. Makes New $5.22 Million Investment in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - January 13 at 12:52 PMOregon Public Employees Retirement Fund Has $3.41 Million Position in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - January 12 at 6:27 AMING Groep NV Lowers Stock Holdings in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - January 11 at 7:46 AMSGEN Jan 2024 210.000 putca.finance.yahoo.com - December 30 at 8:22 AMSGEN Jan 2024 235.000 put(CONTRca.finance.yahoo.com - December 30 at 8:22 AMSGEN Dec 2023 195.000 put(CONTRuk.finance.yahoo.com - December 30 at 12:59 AMPro Research: Wall Street dives into Seagen's oncology advancesza.investing.com - December 27 at 8:07 AMHBM Gets Health Boost From Drug Licensing Dealsseekingalpha.com - December 22 at 8:08 AMPfizer Shares Slump After Waning Covid Sales Hurt 2024 Outlookmsn.com - December 14 at 7:50 AMPfizer: From pandemic hero to investor jitters (SGEN)marketbeat.com - December 14 at 7:00 AMmarketbeat.com - December 14 at 6:06 AMTake-Two Interactive Software to replace Seagen on Nasdaq-100 Indexseekingalpha.com - December 13 at 2:58 PMPfizer to Establish New Oncology Division Following Completion of Seagen Dealmsn.com - December 13 at 8:29 AMPfizer slips as 2024 guidance with Seagen buyout disappointsmsn.com - December 13 at 8:29 AMGTS Securities LLC Makes New $14.89 Million Investment in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - December 13 at 4:35 AMPolar Asset Management Partners Inc. Makes New $12.92 Million Investment in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - December 12 at 10:53 AMPfizer gets OK for $43-bln Seagen deal after donating cancer drug rightsnasdaq.com - December 12 at 10:32 AMWhat the Options Market Tells Us About Seagenbenzinga.com - December 11 at 5:39 PMSeagen Inc. (NASDAQ:SGEN) Shares Acquired by Hudson Bay Capital Management LPmarketbeat.com - December 11 at 11:51 AM88% of patients with advanced stage classical Hodgkin Lymphoma in trial remained progression free at 24 months –businesswire.com - December 11 at 12:58 AMADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphomafinance.yahoo.com - December 10 at 7:58 PMCanyon Capital Advisors LLC Makes New $20.47 Million Investment in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - December 10 at 9:46 AMA Closer Look at Seagen's Options Market Dynamicsbenzinga.com - December 8 at 7:13 PMMarshall Wace LLP Grows Stock Holdings in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - December 8 at 8:48 AM$100 Invested In Seagen 20 Years Ago Would Be Worth This Much Todaybenzinga.com - December 7 at 12:59 PMSeagen's breast cancer drug shows positive results in combination therapy trialmsn.com - December 6 at 3:14 PMSeagen: HER2CLIMB-02 Study Results Reinforce Clinical Activity Of TUKYSAmarkets.businessinsider.com - December 6 at 10:14 AMTUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancerfinance.yahoo.com - December 6 at 10:14 AMSeagen gains amid options trades, optimism for FTC approval for Pfizer dealmsn.com - December 5 at 5:50 PMPolar Capital Holdings Plc Reduces Stock Holdings in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - December 3 at 11:11 AMSeagen Stock (NASDAQ:SGEN), Guidance and Forecastbenzinga.com - December 3 at 10:06 AMWhy Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?finance.yahoo.com - December 1 at 2:50 PMSeagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tagfinance.yahoo.com - December 1 at 9:49 AMBlackRock Inc. Has $2.32 Billion Position in Seagen Inc. (NASDAQ:SGEN)marketbeat.com - December 1 at 8:28 AMFDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV ® (enfortumab vedotin-ejfv) with KEYTRUDA ® (pembrolizumab) for First-Line ...businesswire.com - November 30 at 9:34 PMFDA to decide on approving Keytruda/Padcev combo therapy by May 9msn.com - November 30 at 9:34 PM Get Seagen News Delivered to You Automatically Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). SGEN Media Mentions By Week SGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGEN News Sentiment▼0.000.41▲Average Medical News Sentiment SGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGEN Articles This Week▼05▲SGEN Articles Average Week Get Seagen News Delivered to You Automatically Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Takeda Pharmaceutical News IQVIA News IDEXX Laboratories News Moderna News Alcon News GE HealthCare Technologies News Centene News Cencora News Humana News Haleon News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGEN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
